Delaware-based W L Gore & Associates announced that it will be introducing its Conformable GORE TAG Thoracic Endoprosthesis in the United States after it received approval from the Food and Drug Administration.
The company revealed that its device is the only thoracic endoprosthesis approved by the FDA for treating young trauma patients who have isolated lesions of the thoracic aorta. The company added that the device is easy to use and accommodates "tapered anatomy and resisting compression."
AdvertisementStating that the device will provide conformability with every patient, David Abeyta, Gore Aortic Business Leader said, "We are proud to deliver to endovascular specialists and their patients the first FDA approved minimally invasive treatment option for treating traumatic aortic transaction."
P Genetic Discovery may Lead to Early Detection of Ovarian Cancer Mutation Boosts Ovarian Cancer Survival M
You May Also Like